Fennec Pharmaceuticals, Inc.

Overview

Date Founded

2011

Headquarters

Research Triangle Park,68 T.W. Alexander Drive,Durham, NC 27709

Type of Company

Public

Employees (Worldwide)

4

Industries

Pharmaceuticals
Biotechnology

Company Description

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Website

http://www.fennecpharma.com

Contact Data

Trying to get in touch with decision makers at Fennec Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!

In The News

DirectorsTalk Interviews

January 18, 2021

Fennec Pharmaceuticals Inc. – Consensus Indicates Potential 103.0% Upside

DirectorsTalk Interviews

January 15, 2021

Fennec Pharmaceuticals Inc. – Consensus Indicates Potential 98.7% Upside

DirectorsTalk Interviews

January 14, 2021

Fennec Pharmaceuticals Inc. – Consensus Indicates Potential 104.4% Upside

DirectorsTalk Interviews

December 29, 2020

Fennec Pharmaceuticals Inc. – Consensus Indicates Potential 109.5% Upside

News Bites Canadian Markets

December 11, 2020

Quarterly Report Analysis Q3 2020: Fennec Pharmaceuticals reports deterioration in Loss Corporate Wire Date: 10 December 2020 13:30 EST Release Date: November 30, 2020

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

Executives & Employees

Rostislav C. Raykov

Chairman of the Board & Chief Executive Officer

Robert C. Andrade

Chief Financial Officer & Principal Accounting Officer

Shubh Goel

Chief Commercial Officer

Mark Gowland

Controller

Lei Fang

Member, Management Team

Paul A. Dreyer

Member, Management Team

Krysia Lynes

Chief Financial Officer

Board of Directors

Khalid Islam

Partner at Sirius Healthcare Partners GmbH

Adrian James Haigh

Senior Vice President & General Manager-EMEA Region at PTC Therapeutics, Inc.

Chris A. Rallis

Jodi A. Cook

Chief Operating Officer at Agilis Biotherapeutics, Inc.

Marco Maria Brughera

Chief Executive Officer & Global Head, Rare Disease-Sigma Tau Rare Disease Ltd at ESSETIFIN SpA

Trending Organizations

Paths to Fennec Pharmaceuticals, Inc.

Potential Connections via
Relationship Science

You

Fennec Pharmaceuticals, Inc.

Owners & Shareholders

Details Hidden

Southpoint Capital Advisors LP

SCA is a value-oriented investment adviser that focuses primarily on US corporate equity, but also invests in other securities and investments on behalf of the Funds. Their funds seek high absolute investment returns, while minimizing the risk of capital loss, by purchasing securities and other financial instruments with trading values substantially below their intrinsic value and selling short securities and other financial instruments with trading values substantially above their intrinsic value. The firm primarily constructs its portfolio from the bottom-up.

Details Hidden

Solas Capital Management LLC

SCM’s investment approach focuses on fundamental value with respect to specific securities, both in long and short strategies, that intends both to achieve absolute investment returns and preserve capital, irrespective of market conditions. The firm uses primary research and fundamental bottom-up analysis in an attempt to develop a deep, fundamental view of companies and to identify opportunities across investment instruments.

Details Hidden

Solas Capital Management LLC

SCM’s investment approach focuses on fundamental value with respect to specific securities, both in long and short strategies, that intends both to achieve absolute investment returns and preserve capital, irrespective of market conditions. The firm uses primary research and fundamental bottom-up analysis in an attempt to develop a deep, fundamental view of companies and to identify opportunities across investment instruments.

Recent Transactions

Details Hidden

Fennec Pharmaceuticals, Inc. issued USD Common Shares

Details Hidden

Fennec Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Fennec Pharmaceuticals, Inc. raised money in a private placement transaction

Transaction Advisors

Auditor

PricewaterhouseCoopers LLP (Canada)

Advised onFennec Pharmaceuticals, Inc. issued CAD Units

Underwriter

Versant Partners, Inc.

Advised onFennec Pharmaceuticals, Inc. issued CAD Units

Escrow Agent

Computershare Trust Co., Inc.

Advised onFennec Pharmaceuticals, Inc. issued USD Common Shares

Legal Advisor

Garett M. Sleichter

Advised onFennec Pharmaceuticals, Inc. issued USD Common Shares

Legal Advisor

Randy Taylor

Advised onFennec Pharmaceuticals, Inc. issued USD Common Shares

Head of Investment Banking

Sage Kelly

Advised onFennec Pharmaceuticals, Inc. issued USD Common Shares

Key Stats and Financials As of 2019

Market Capitalization

$193M

Total Enterprise Value

$110M

Earnings Per Share

$-0.62

TEVNet Income

-8.87x

Debt TEV

0x

Three Year Compounded Annual Growth Rate Of Revenue

0%

Five Year Compounded Annual Growth Rate Of Revenue

0%

Revenue

$0

Net Profit

$-12.4M

EBITDA

$-12.6M

Total Debt

$0

Total Equity

$11.3M

Non-Profit Donations & Grants

$10K - $50K

2006

Case Western Reserve University - School of Medicine

Suppliers

Oregon Health & Science University Hospitals & Patient Services | Portland, OR

Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. OHSU is the kind of place where the big news doesn't always involve sports, politics, fashion or even weather. The big news is always about health — health care, health education, health-related research. And various organizations and publications that rank American institutions, programs and faculty in a variety of categories have taken note. Nearly one million patient visits each year. Educating thousands of future health care providers. You get the picture. Immerse yourself in more facts and stats than you probably need about Portland's largest employer, Oregon's provider of care to every corner of the state, and one of the nation's top 28 biomedical research institutions. Oregon Health & Science University is the state’s only academic health center. It provides an uncommon array of services from providing the state’s most comprehensive health care, to educating the next generation of clinicians and biomedical researchers, to achieving breakthroughs and innovations.

Competitors

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.